Kigali, Rwanda and San Francisco, USA – 14 February 2026 — Bio Usawa congratulates two African health leaders, Dr. Delese Mimi Darko and Dr. Sabin Nsanzimana, who have been named to TIME Magazine’s TIME100 Health 2026 under the “Titans” category, underscoring Africa’s growing leadership in shaping global health security and systems transformation.

Dr. Darko, a pharmacist and former Chief Executive Officer of Ghana’s Food and Drugs Authority, is recognized for her pioneering role as the first Director-General of the African Medicines Agency (AMA). The agency was established to harmonize and strengthen medicines regulation on the continent.

Under her leadership, the AMA is working to streamline regulatory processes across Africa, with the goal of securing participation from all 55 African Union member states. To date, 32 countries have joined the treaty, marking significant progress toward regulatory convergence and improved access to safe, quality-assured medical products.

Dr. Sabin Nsanzimana, Rwanda’s Minister of Health, is being honored for his decisive leadership during Rwanda’s first-ever Marburg virus outbreak in late 2024.

Marburg virus, a highly fatal hemorrhagic illness related to Ebola, has historically claimed up to 88 percent of those infected in past outbreaks. Rwanda’s rapid response — marked by immediate contact tracing, testing, and coordination with international partners proved pivotal. By December 20, 2024, the outbreak had been contained. Of 66 confirmed cases, 15 deaths were recorded, and the virus was prevented from spreading beyond Rwanda. The response has since informed global outbreak management strategies, demonstrating the power of preparedness, swift decision-making, and international collaboration.

Commenting on the two leaders’ recognition, Dr. Patrick Lukulay, Chief Operating Officer of Bio Usawa, said: “Dr. Darko and Dr. Nsanzimana represent the caliber of leadership that is redefining Africa’s role in global health. Their recognition by TIME affirms what many of us already know — that African institutions and leaders can set global standards, not merely aspire to them.”

Together, the recognition of Dr. Darko and Dr. Nsanzimana signals a broader shift: Africa is not only responding to health challenges — it is helping define the standards and systems that shape global health resilience. Their leadership reflects a continent increasingly committed to regulatory excellence, rapid innovation, and coordinated public health action.

About Bio Usawa

Bio Usawa is Africa’s pioneering biotechnology company dedicated to democratizing access to life-saving biotherapeutics. Headquartered in Kigali, Rwanda, the company develops, licenses, and manufactures affordable monoclonal antibodies and biosimilars targeting cancer, diabetes complications, infectious diseases, and autoimmune conditions.

Dr. Delese Mimi Darko (left), AMA Director General, and Dr. Sabin Nsanzimana (right),
Rwanda’s Minister of Health.